CD8A and neoplasm: The treatment of mice with NGR–TNF-α, a fusion form of TNF-α with a tumor-homing peptide recognizing specifically TECs, induced intra-tumor upregulation of CAMs, and the infiltration of tumor-specific effector CD8+ T cells.